Financial Information for the Company and Its Subsidiaries (Tables)

3 Months Ended

Mar. 31, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]



Condensed Consolidating Balance Sheet - March 31, 2016 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	9,391	$	20,632	$	55,860	$	—		$	85,883
Restricted cash and marketable securities	—		995		13,440		—			14,435
Accounts receivable, net	—		240,265		112,626		—			352,891
Supplies inventory	—		—		21,584		—			21,584
Prepaid and other current assets	39,908		31,317		28,637		(23,349		)	76,513
Total current assets	49,299		293,209		232,147		(23,349		)	551,306
Property and equipment, net	12,421		17,824		161,675		—			191,920
Investments in and receivables from unconsolidated affiliates	4,901,556		1,774,642		—		(6,503,372		)	172,826
Goodwill	—		1,954,467		—		2,013,435			3,967,902
Intangible assets, net	13,142		1,565,068		2,127		—			1,580,337
Other assets	4,532		1,583		15,538		(1,998		)	19,655
Total assets	$	4,980,950	$	5,606,793	$	411,487	$	(4,515,284	)	$	6,483,946
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	19	$	11,512	$	—		$	20,231
Accounts payable	2,196		2,080		26,223		(4,087		)	26,412
Accrued salaries and benefits	25,225		162,396		16,570		—			204,191
Accrued interest	17,995		—		10		—			18,005
Other accrued liabilities	8,125		67,058		45,940		(19,262		)	101,861
Total current liabilities	62,241		231,553		100,255		(23,349		)	370,700
Long-term debt	2,306,032		40		54,587		(24,375		)	2,336,284
Deferred income taxes	281,498		426,952		—		(1,998		)	706,452
Other long-term liabilities	4,658		73,729		20,620		—			99,007
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		61,577		113,094			174,671
Equity:
Total AmSurg Corp. equity	2,326,521		3,646,362		128,291		(3,774,653		)	2,326,521
Noncontrolling interests – non-redeemable	—		—		46,157		424,154			470,311
Total equity	2,326,521		3,646,362		174,448		(3,350,499		)	2,796,832
Total liabilities and equity	$	4,980,950	$	5,606,793	$	411,487	$	(4,515,284	)	$	6,483,946



Condensed Consolidating Balance Sheet - December 31, 2015 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	20,437	$	27,507	$	58,716	$	—		$	106,660
Restricted cash and marketable securities	—		—		13,506		—			13,506
Accounts receivable, net	—		223,434		113,896		—			337,330
Supplies inventory	—		—		21,406		—			21,406
Prepaid and other current assets	28,739		39,046		16,062		(8,076		)	75,771
Total current assets	49,176		289,987		223,586		(8,076		)	554,673
Property and equipment, net	12,515		14,601		162,052		—			189,168
Investments in and receivables from unconsolidated affiliates	4,901,026		1,775,272		—		(6,507,128		)	169,170
Goodwill	—		1,956,741		—		2,013,469			3,970,210
Intangible assets, net	12,780		1,579,537		2,320		—			1,594,637
Other assets	4,653		1,717		17,078		(1,998		)	21,450
Total assets	$	4,980,150	$	5,617,855	$	405,036	$	(4,503,733	)	$	6,499,308
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	11,677	$	—		$	20,377
Accounts payable	2,816		3,760		29,837		(3,852		)	32,561
Accrued salaries and benefits	31,510		158,705		12,322		—			202,537
Accrued interest	30,463		—		17		—			30,480
Other accrued liabilities	13,962		76,590		32,909		(4,224		)	119,237
Total current liabilities	87,451		239,055		86,762		(8,076		)	405,192
Long-term debt	2,326,103		—		55,249		(23,396		)	2,357,956
Deferred income taxes	268,573		432,923		—		(1,998		)	699,498
Other long-term liabilities	4,560		71,509		20,114		—			96,183
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		63,060		112,672			175,732
Equity:
Total AmSurg Corp. equity	2,293,463		3,646,211		132,267		(3,778,478		)	2,293,463
Noncontrolling interests – non-redeemable	—		—		47,584		423,700			471,284
Total equity	2,293,463		3,646,211		179,851		(3,354,778		)	2,764,747
Total liabilities and equity	$	4,980,150	$	5,617,855	$	405,036	$	(4,503,733	)	$	6,499,308

Condensed Consolidating Statement of Operations



Condensed Consolidating Statement of Operations - For the Three Months Ended March 31, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	8,544		$	415,830	$	310,612	$	(10,308	)	$	724,678
Operating expenses:
Salaries and benefits	24,095			309,580		76,297		(133		)	409,839
Supply cost	—			1,007		45,969		(13		)	46,963
Other operating expenses	7,618			43,339		66,887		(10,162		)	107,682
Transaction costs	177			1,213		—		—			1,390
Depreciation and amortization	1,072			20,336		7,664		—			29,072
Total operating expenses	32,962			375,475		196,817		(10,308		)	594,946
Equity in earnings of unconsolidated affiliates	69,042			65,436		—		(127,899		)	6,579
Operating income	44,624			105,791		113,795		(127,899		)	136,311
Interest expense (income), net	(2,819		)	32,976		653		—			30,810
Earnings before income taxes	47,443			72,815		113,142		(127,899		)	105,501
Income tax expense	16,580			3,774		443		—			20,797
Net earnings	30,863			69,041		112,699		(127,899		)	84,704
Less net earnings attributable to noncontrolling interests	—			—		53,841		—			53,841
Net earnings attributable to AmSurg Corp. shareholders	30,863			69,041		58,858		(127,899		)	30,863
Preferred stock dividends	(2,264		)	—		—		—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	28,599		$	69,041	$	58,858	$	(127,899	)	$	28,599



Condensed Consolidating Statement of Operations - For the Three Months Ended March 31, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Net revenue	$	7,091		$	285,579		$	286,629		$	(8,854	)	$	570,445
Operating expenses:
Salaries and benefits	17,643			211,601			73,063			(128		)	302,179
Supply cost	—			396			42,188			—			42,584
Other operating expenses	6,634			29,611			63,051			(8,726		)	90,570
Transaction costs	268			1,203			—			—			1,471
Depreciation and amortization	834			14,307			7,677			—			22,818
Total operating expenses	25,379			257,118			185,979			(8,854		)	459,622
Net loss on deconsolidations	(188		)	(188		)	(35		)	188			(223		)
Equity in earnings of unconsolidated affiliates	60,387			54,583			—			(112,319		)	2,651
Operating income	41,911			82,856			100,615			(112,131		)	113,251
Interest expense, net	11,886			17,754			607			—			30,247
Earnings before income taxes	30,025			65,102			100,008			(112,131		)	83,004
Income tax expense	8,987			4,903			359			—			14,249
Net earnings	21,038			60,199			99,649			(112,131		)	68,755
Less net earnings attributable to noncontrolling interests	—			—			47,717			—			47,717
Net earnings attributable to AmSurg Corp. shareholders	21,038			60,199			51,932			(112,131		)	21,038
Preferred stock dividends	(2,264		)	—			—			—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	18,774		$	60,199		$	51,932		$	(112,131	)	$	18,774

Condensed Consolidating Statement of Cash Flows



Condensed Consolidating Statement of Cash Flows - For the Three Months Ended March 31, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by operating activities	$	18,122		$	72,860		$	122,490		$	(131,699	)	$	81,773
Cash flows from investing activities:
Acquisitions and related expenses	—			(2,990		)	—			—			(2,990		)
Acquisition of property and equipment	(1,509		)	(7,320		)	(6,862		)	—			(15,691		)
Maturities of marketable securities	—			—			2,240			—			2,240
Other	—			(878		)	(631		)	—			(1,509		)
Net cash flows used in investing activities	(1,509		)	(11,188		)	(5,253		)	—			(17,950		)
Cash flows from financing activities:
Proceeds from long-term borrowings	15,000			—			1,197			—			16,197
Repayment on long-term borrowings	(37,175		)	—			(3,157		)	—			(40,332		)
Distributions to owners, including noncontrolling interests	—			(68,547		)	(119,953		)	131,699			(56,801		)
Changes in intercompany balances with affiliates, net	(979		)	—			979			—			—
Other, net	(4,505		)	—			841			—			(3,664		)
Net cash flows used in financing activities	(27,659		)	(68,547		)	(120,093		)	131,699			(84,600		)
Net decrease in cash and cash equivalents	(11,046		)	(6,875		)	(2,856		)	—			(20,777		)
Cash and cash equivalents, beginning of period	20,437			27,507			58,716			—			106,660
Cash and cash equivalents, end of period	$	9,391		$	20,632		$	55,860		$	—		$	85,883



Condensed Consolidating Statement of Cash Flows - For the Three Months Ended March 31, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by (used in) operating activities	$	(33,779	)	$	91,981		$	102,821		$	(62,196	)	$	98,827
Cash flows from investing activities:
Acquisitions and related expenses	(62,056		)	(127,047		)	—			62,525			(126,578		)
Acquisition of property and equipment	(2,678		)	(2,538		)	(9,567		)	—			(14,783		)
Other	—			(1,322		)	1,102			—			(220		)
Net cash flows used in investing activities	(64,734		)	(130,907		)	(8,465		)	62,525			(141,581		)
Cash flows from financing activities:
Proceeds from long-term borrowings	—			—			2,227			—			2,227
Repayment on long-term borrowings	(2,175		)	—			(3,038		)	—			(5,213		)
Distributions to owners, including noncontrolling interests	—			(10,241		)	(99,157		)	62,196			(47,202		)
Capital contributions	—			62,056			—			(62,056		)	—
Changes in intercompany balances with affiliates, net	(2,573		)	—			2,573			—			—
Other, net	(972		)	2,321			139			(469		)	1,019
Net cash flows provided by (used in) financing activities	(5,720		)	54,136			(97,256		)	(329		)	(49,169		)
Net increase (decrease) in cash and cash equivalents	(104,233		)	15,210			(2,900		)	—			(91,923		)
Cash and cash equivalents, beginning of period	134,351			23,471			50,257			—			208,079
Cash and cash equivalents, end of period	$	30,118		$	38,681		$	47,357		$	—		$	116,156